Vir Biotechnology, Inc.VIRNASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank25
3Y CAGR+80.3%
5Y CAGR-23.8%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
+80.3%/yr
vs -80.9%/yr prior
5Y CAGR
-23.8%/yr
Recent acceleration
Acceleration
+161.3pp
Accelerating
Percentile
P25
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
2 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 12.18 | -9.6% |
| 2024 | 13.48 | -13.9% |
| 2023 | 15.66 | +653.8% |
| 2022 | 2.08 | -58.2% |
| 2021 | 4.96 | -89.5% |
| 2020 | 47.45 | -97.5% |
| 2019 | 1904.67 | +21.7% |
| 2018 | 1565.34 | +138.6% |
| 2017 | 656.16 | - |